Unregistered Sales of Equi ty Securities and Use of Proceeds
+Added: Unregistered Sales of Equity Securities
+Added: During the three-month period ended March 31, 2025, we issued 0.3 million shares of our common stock valued at $27.8 million upon the achievement of a commercial milestone related to the Embody acquisition.
+Added: The shares were issued to the former Embody shareholders whom we reasonably believed to be accredited investors in a private transaction exempt from registration under Section 4(a)(2) and Regulation D under the Securities Act.
Issuer Purchases of Equity Securities
−Removed: The following table summarizes repurchases of common stock settled during the three-month period ended September 30, 2024:
+Added: The following table summarizes repurchases of common stock settled during the three-month period ended March 31, 2025:
Total Number of Shares Purchased
4 unchanged sentences
1,249,999,420
+Added: February 2025
1,163,483,012
−Removed: September 2024
1,020,224,454
1,020,224,454
−Removed: (1) In May 2024, our Board of Directors authorized a $2.0 billion share repurchase program effective May 29, 2024, with no expiration date.
−Removed: Subsequent to September 30, 2024 through October 9, 2024, we repurchased an additional 0.6 million shares for $58.1 million, resulting in $1,250.0 million remaining authorized under the May 2024 program as of October 9, 2024.
+Added: (1) In May 2024, our Board of Directors authorized a $2.0 billion share repurchase program with no expiration date.
Defaults Upo n Senior Securities
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.